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A. SUPPLEMENTARY FIGURES S1 AND S2 Figure S1 . P. aeruginosa PA14 growth is not affected by PqsA inhibitors (1.5 mM) at 20 h. Figure S2 . P. aeruginosa PA14 production of pyocyanin is not inhibited by PqsA inhibitors (1.0 mM) at 24 h.
B. MATERIALS AND METHODS

Chemical Synthesis
Reagents were obtained from Aldrich Chemical (www.sigma-aldrich.com) or Acros Organics (www.fishersci.com) and used without further purification. Optima or HPLC grade solvents were obtained from Fisher Scientific (www.fishersci.com), degassed with Ar, and purified on a solvent drying system. Reactions were performed in flame-dried glassware under positive Ar pressure with magnetic stirring.
TLC was performed on 0.25 mm E. Merck silica gel 60 F254 plates and visualized under UV light (254 nm) or by staining with potassium permanganate (KMnO4), cerium ammonium molybdenate (CAM), or iodine (I 2 ). Silica flash chromatography was performed on E. Merck 230-400 mesh silica gel 60. Samples were lyophilized using a Labconco Freezone 2.5 instrument.
NMR spectra were recorded on a Bruker Avance III 500 instrument or Bruker Avance III 600 instrument at 24 °C in CDCl 3 unless otherwise indicated. Spectra were processed using Bruker TopSpin or nucleomatica iNMR (www.inmr. 92, 157.26, 153.94, 151.28, 150.43, 141.48, 133.13, 132.58, 120.10, 119.93, 117.94, 116.75, 115.21, 91.91, 85.69, 83.42, 69.61, 47.80, 27.46, 25.46, 9.19 
Cs 2 CO 3
Anthranilyl-AMS (1). In a 25-mL roundbottom flask, protected anthranilyl-AMS S1 (750 mg, 1.48 mmol) was dissolved in 80% aq TFA (10 mL) and stirred for 2 h. The reaction mixture was concentrated by rotary evaporation. Purification by silica flash chromatography (10-20% MeOH in EtOAc with 1% Et 3 N) afforded anthranilyl-AMS as its Et 3 N salt (580 mg, 84%). The Et 3 N salt was then converted to the corresponding sodium salt using the general procedure for ionexchange (above) to afford anthranilyl-AMS, sodium salt (500 mg, 100%) as a white solid. 98, 155.36, 152.55, 148.81, 147.73, 139.65, 132.52, 130.45, 119.39, 118.55, 117.46, 117.41, 86.96, 82.40, 73.44, 70.11, 68.48 In a 100-mL roundbottom flask, N 6 -Boc-2′,3′-O-isopropylideneadenosine, prepared as previously described 4 37, 151.77, 150.47, 150.34, 149.67, 141.73, 122.48, 115.37, 89.93, 85.40, 85.18, 84.50, 82.63, 82.14, 77.44, 77.23, 77.02, 48.38, 28.34, 28.24, 27.45, 25.67 
Protected anthranilyl-AMSN (S3).
In a 50-mL roundbottom flask, protected AMSN S2 (800 mg, 1.37 mmol, 1 equiv) and N-Boc-anthranilic acid NHS ester, prepared as previously described 5 (502 mg, 1.50 mmol, 1.1 equiv), were dissolved in 20 mL CH 3 CN. DBU (420 mg, 2.74 mmol, 2.0 equiv) was added dropwise and the mixture was stirred at room temperature for 3 h. The reaction mixture was concentrated by rotary evaporation and the residue was partitioned between 0.2 N HCl (20 mL) and EtOAc (20 mL). The aqueous layer was extracted with EtOAc (3×20 mL), dried (Na 2 SO 4 ), and concentrated by rotary evaporation. Purification by silica flash chromatography (50-100% EtOAc in hexanes) yielded protected anthranilyl-AMSN S3 (760 mg, 69%) as a white solid. 25, 154.61, 153.37, 152.43, 152.04, 151.45, 144.34, 141.67, 133.19, 132.68, 124.09, 123.55, 122.10, 119.73, 115.50, 91.62, 87.16, 85.78, 85.40, 83.94, 82.89, 80.98, 28.66, 28.47, 28.36, 27.54, 25.58 Am. Chem. Soc. 1996 , 118, 2332 -2339 .
H NMR (500 MHz
Anthranilyl-AMSN (2). In a 25-mL roundbottom flask, protected anthranilyl-AMSN S3 (700 mg, 0.87 mmol) was dissolved in 80% aq TFA (5 mL). After 2 h, the reaction mixture was diluted with water (20 mL) and extracted with ether (5×25 mL). The aqueous layer was lyophilized to afford anthranilyl-AMSN 2 (400 mg, 100%) as a white solid. 88, 153.01, 151.97, 149.47, 147.39, 144.68, 135.03, 129.99, 121.39, 118.29, 116.95, 113.24, 91.79, 85.98, 74.96, 73.03, 46.24 
H NMR (500
Salicyl-AMS (3).
This compound was prepared as previously described 6 and converted to sodium salt using the general procedure for ion exchange. 47, 158.57, 155.24, 152.40, 148.63, 139.75, 134.07, 129.38, 119.13, 118.56, 117.88, 116.39, 87.33, 82.15, 73.16, 70.01, 69.32 
Salicyl-AMSN (4).
This compound was prepared as previously described 7 and converted to sodium salt using the general procedure for ion exchange. 98, 158.55, 155.41, 152.53, 148.46, 140.60, 133.79, 129.18, 119.18, 118.41, 116.47, 87.96, 83.39, 72.92, 71.15, 45.14 
Benzoyl-AMS (5).
This compound was prepared as previously described 8 and converted to sodium salt using the general procedure for ion exchange. 35, 157.22, 153.82, 150.81, 141.16, 138.90, 132.08, 129.88, 128.79, 120.11, 89.16, 84.72, 76.14, 72.43, 69.25 tert-Butyl ((2-hydroxy-2-(2-nitrophenyl)ethyl)sulfonyl)carbamate (S4). In a 100-mL roundbottom flask, tert-butyl (methylsulfonyl)carbamate 1 (600 mg, 3.07 mmol, 1.0 equiv) was dissolved in 15 mL of THF and the solution was cooled to -78 °C. n-BuLi (3.84 mL, 6.14 
S7
tert-Butyl (E)-((2-nitrostyryl)sulfonyl)carbamate (S5).
In a 50-mL roundbottom flask, benzyl alcohol S4 (500 mg, 1.45 mmol, 1.0 equiv) was dissolved in 14.5 mL of CH 2 Cl 2 and the solution was cooled to 0 °C. Triethylamine (0.6 mL, 4.35 mmol, 3.0 equiv) was added followed by methanesulfonyl chloride (0.168 mL, 2.18 mmol, 1.5 equiv). The resulting solution was stirred at 0 ºC for 2 h, then heated to reflux for 6 h. The mixture was quenched with saturated sodium bicarbonate solution and the aqueous layer was separated and extracted with CH 2 Cl 2 (2×50 mL). The combined organic extracts were washed with brine, dried (Na 2 SO 4 ), filtered, and concentrated by rotary evaporation. Purification by silica flash chromatography (0-40% EtOAc in hexanes ) afforded 2-nitrophenylvinyl sulfonamide S5 (351 mg, 74%) as a light yellow oil. 
TLC:
tert-Butyl (E)-((2-aminostyryl)sulfonyl)carbamate (S6).
In a 5-mL conical vial, 2-nitrophenylvinyl sulfonamide S5 (300 mg, 0.92 mmol, 1.0 equiv) and SnCl 2 2H 2 O (1.04 g, 4.6 mmol, 5.0 equiv) were dissolved in 2 mL of EtOH and heated at 40 °C for 1 h. The solution was allowed to cool to room temperature, poured onto ice (10 g), and basified with 5% aqueous sodium bicarbonate. The resulting mixture was extracted with EtOAc (3×50 mL), dried (Na 2 SO 4 ), and concentrated by rotary evaporation. The crude 2-aminophenylvinyl sulfonamide S6 was used for the next step without purification. 150.9, 150.4, 150.0, 149.5, 146.0, 141.9, 139.5, 132.2, 128.5, 124.3, 122.3, 119.0, 117.6, 117.0, 114.6, 90.5, 85.7, 84.8, 84.3, 82.5, 82.3, 47.5, 28.1, 28.0, 27.9, 27.1, 25.3 
Anthranilyl-AVSN (6).
In a 10-mL roundbottom flask, 2-aminophenylvinyl sulfonamide S7 (70 mg, 0.1 mmol) was dissolved in CH 2 Cl 2 (1 mL). 80% Aqueous TFA (1 mL) was added and the solution was stirred at 0 °C for 1 h, then at room temperature for 4 h. The resulting solution was azeotroped with toluene (2×10 mL) and concentrated by rotary evaporation. Purification by silica flash chromatography (10:1 EtOAc/MeOH) afforded anthranilyl-AVSN 6 (39 mg, 85%) as a waxy solid. 6, 152.3, 150.0, 148.4, 142.7, 138.3, 132.7, 128.8, 125.0, 121.1, 119.4, 119.0, 118.3, 91.3, 85.9, 74.6, 72.9, 45.6 
2-Heptylquinolin-4(1H)-one-5,6,7,8-d 4 (HHQ-d 4 )
. 10 In a 100-mL roundbottom flask, aniline-d 5 (1.0 g, 10.2 mmol, 1.0 equiv) and methyl 3-oxodecanoate 11 (2.5 g, 12.50 mmol, 1.2 equiv) were dissolved in dry hexanes (35 mL). p-Toluenesulfonic acid (100 mg) was added and the mixture heated to reflux for 12 h under a Dean-Stark trap to remove water. The mixture was allowed to cool to room temperature then concentrated by rotary evaporation. The crude enamine S8 was used without further purification.
In a 25-mL roundbottom flask equipped with a distillation head and collecting flask, diphenyl ether (8 mL) was heated to reflux (280 °C). The crude enamine S8 was added dropwise over 10 min, then the mixture was stirred at reflux (280 °C) for an additional 30 min as the methanol byproduct was removed by distillation. The mixture was then cooled to room temperature, whereupon it solidified. Purification by silica flash chromatography (1:1 EtOAc/hexanes → EtOAc → 1:19 MeOH/EtOAc) afforded HHQ-d 4 (1.4 g, 68% over 2 steps) as a white solid.
TLC: R f 0.4 (19:1 EtOAc/CH 3 OH).
1 H-NMR (600 MHz, CD 3 OD): 1 exchangable proton δ 6.22 (s, 1H), 2.71 (t, J = 7.8 Hz, 2H), 1.75 (q, J = 7.6 Hz, 2H), 1.45-1.25 (m, 8H), 0.89 (t, J = 6.8 Hz, 3H).
13 C-NMR (151 MHz) δ 180. 65, 157.17, 141.55, 125.41, 108.81, 35.02, 32.89, 30.22, 30.20, 30.19, 30.15, 30.13, 23.69, 14.41 . 10 In a 50-mL roundbottom flask, HHQ-d 4 (1.14 g, 4.6 mmol, 1.0 equiv), hexamethylenetetramine (323 mg, 2.3 mmol, 0.5 equiv) were dissolved in trifluoroacetic acid (7.0 ml) and heated to reflux for 27 h. Methanol (11 ml) and water (11 ml) were added, and heating was continued for 50 min. Hydrochloric acid (2.5 M, 5 ml) was added, and heating was continued for 30 min. The mixture was allowed to cool to room temperature, then the precipitate was removed by filtration and washed with water to provide the crude aldehyde S9 (1.0 g), which was used without further purification.
In a 25-mL roundbottom flask, aldehyde S9 was dissolved in ethanol (3 mL). Aqueous 30% hydrogen peroxide (0.453 g, 3.99 mmol) was added followed by aqueous sodium hydroxide (1.08 M, 0.75 ml). The mixture was stirred at room temperature for 6 h, then diluted with water and filtered. The resulting solid was washed with water. Purification by silica flash chromatography (1:1 EtOAc/hexanes → EtOAc) afforded PQS-d 4 (121 mg, 10% over 2 steps) as a white solid.
TLC: R f 0.2 (EtOAc only).
1 H-NMR (600 MHz, CD 3 OD): 2 exchangable protons δ 2.91 (t, J = 7.8 Hz, 2H), 1.80 (p, J = 7.6 Hz, 2H), 1.51-1.30 (m, 8H), 0.92 (t, J = 6.7 Hz, 3H).
13 C-NMR (151 MHz) δ 139. 61, 139.60, 138.67, 123.56, 32.92, 30.44, 30.17, 29.82, 29.37, 23.70, 14.42 
PqsA spectrophotometric assay
Reactions were performed at 37 °C in a 0.5 mL volume in a Varian Cary 100 UV-visible spectrophotometer with Cary WinUV software. Reaction mixtures contained 100 mM HEPES, pH 8.0, 0.2 mM dithiothreitol, 2 mM MgCl 2 , ~3.3 µg PqsA protein (~60 nM final), and depending on which substrate varied, 1 mM ATP (disodium salt), 0.5 mM coenzyme A (trilithium salt), 0.5 mM sodium anthranilate, and inhibitor (usually as a DMSO stock solution).
Reactions were blanked and preincubated with all components except anthranilate at 37 °C for 1 min, then initiated by addition of anthranilate. Formation of anthraniloyl-CoA was monitored by absorbance at 365 nm (ε = 5.5 mM -1 cm -1 ) for 1 min. Data were analyzed using GraphPad Prism 6 software.
F. PQS/HHQ AND PYOCYANIN QUANTIFICATION IN P. AERUGINOSA
Bacterial culture and sample preparation
Production of PQS and HHQ by P. aeruginosa strain PA14 was performed in triplicate in 14-mL roundbottom Falcon tubes containing 3-mL cultures in LB medium. Tubes tilted at ~60º angle were incubated at 37 ºC in an orbital shaker at 225 rpm. Cultures were inoculated with 15-h culture in LB to obtain a starting OD 600 = 0.05, with or without inhibitors added. For PQS and HHQ analysis, a 20 µL aliquot of the culture was taken at each time points as indicated. Each sample was diluted with 180 µL MeOH containing 100 µM HHQ-d 4 or PQS-d 4 internal standard and 2% AcOH (10-fold dilution of culture to 200 µL total volume with 90 µM internal standard final concentration). The solution was vortexed and centrifuged at 13,000g for 5 min and the supernatant was transferred to a 96-well plate for LC-MS/MS analysis. Bacterial growth was measured by recording OD 600 at 20 h to provide the data in Figure S1 .
PQS and HHQ quantification by LC-MS/MS analysis
Quantification of PQS and HHQ in bacterial culture supernatants was performed as previously described 12,13 with a slightly modified protocol. LC-MS/MS analysis was carried out on an Agilent Technologies 6410 triple quad LC-MS/MS system with autosampler in electrospray ionization (ESI) mode, with an Agilent Zorbax Eclipse XDB-C18 reverse phase column (50 × 4.6 mm, 5 µm) using a flow rate of 0.5 mL/min and an isocratic mobile phase of 60% CH 3 CN in 0.1% aq formic acid over 5 min. Positive electrospray in MRM mode was employed to quantify PQS and HHQ, using the ion transitions indicated. 
Pyocyanin quantification
Production of pyocyanin by P. aeruginosa strain PA14 was performed in triplicate in roundbottom glass tubes containing 5-mL cultures in LB medium. Tubes tilted at ~60º angle were incubated at 37 ºC in an orbital shaker at 200 rpm. Cultures were inoculated with 15-h preculture in LB in order to obtain a starting OD 600nm = 0.05, with or without inhibitors added. At 24 h, 1 mL of each culture was thoroughly vortexed and centrifuged (12,000 g, 5 min). Next, 0.8 mL of the supernatant was removed and the OD 690nm was measured. The ratio of the absorbance between samples from compound-treated or MvfR -cultures and untreated controls was calculated to provide the data in Figure S2 . 
